Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. - Wikidata - awgldk - TriplyDB

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

http://www.wikidata.org/entity/Q33725032

about

Update in asthma 2009 An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity Clinical usefulness of mepolizumab in severe eosinophilic asthma Challenges in the management of severe allergic asthma in the elderly Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma Biomarkers and severe asthma: a critical appraisal Resolution of inflammation in asthma Bronchial thermoplasty in asthma: current perspectives Chronic rhinosinusitis and asthma: novel understanding of the role of IgE 'above atopy'Endoplasmic reticulum stress and the related signaling networks in severe asthma Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities Asthma heterogeneity and severity The Danish National Database for Asthma: establishing clinical quality indicators Management of the patient with eosinophilic asthma: a new era begins Therapeutic interventions in severe asthma Challenges in the Management of Asthma in the Elderly STROBE-compliant article: Is continuity of care associated with avoidable hospitalization among older asthmatic patients?Facteurs associes a l'asthme sévère chez les patients asthmatiques suivis au Centre National Hospitalier de Pneumo-phtisiologie de Cotonou (Benin) en 2014 Altered Innate Immune Responses in Neutrophils from Patients with Well- and Suboptimally Controlled Asthma Adult-onset asthma becomes the dominant phenotype among women by age 40 years. the longitudinal CARDIA study Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene How variability in clinical phenotypes should guide research into disease mechanisms in asthma Traffic-Related Air Pollution and Telomere Length in Children and Adolescents Living in Fresno, CA: A Pilot Study.Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012 Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II.Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity.Quantitative assessment of multiscale structural and functional alterations in asthmatic populations Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program.Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma Biomarkers in asthma: a real hope to better manage asthma.Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.S-nitrosoglutathione reductase in human lung cancer Asthma outcomes: pulmonary physiology.Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.Obesity and asthma: an association modified by age of asthma onset.

P2860

Q24599763-D3E786C9-A8C9-454C-AA6D-27C153D9963B Q24645999-D2478600-1174-47DB-9677-E08244FB80E8 Q26746215-B3419B6A-FD93-4629-B025-68860E8BAD4D Q26751301-C57857CE-9594-4F12-849D-1226708F0140 Q26777154-E0941DEF-BFD9-4672-8F9B-51FCDA3F5E22 Q26779940-E2BAF0F4-264A-46F2-B37E-64988100C4B2 Q26782718-D6631078-7403-42A0-8FCA-ED835A47E16D Q26823724-7A1333CB-CB17-4159-9087-A8A3B0BDCBA7 Q26852643-3464BE82-AF64-4498-B140-0BB3C0C41C79 Q26861024-52569E59-893A-4120-ACFA-E60C78564B3E Q27001541-87927940-DAD5-4DED-ADDC-825E4F9FCEE3 Q27694579-C04E64EB-9A1B-4E2C-9258-B8885D17FCAF Q28072301-D3E7332C-5335-4191-9021-AA0BEC6E34E8 Q28074257-9FF856E4-AFA8-4826-AFAD-CF571DB2E766 Q28078191-70D9A640-FF1D-4105-AD5B-68A66071FCAD Q28079238-9CDABBFE-88E6-4119-98A8-DE70AE0A6AEA Q28087045-15F4B856-26BB-45A3-B25F-759D7E69D18C Q28390519-6C01972B-7AAD-4784-AD89-63920E8880A8 Q28393915-68A5DBE6-FD58-4F94-B1D3-18EDF1482CE5 Q28395377-CE9B92F2-8E81-4C69-9A81-29614BE00C07 Q28397837-92C61230-1133-44CB-82CC-57CA6EFCB6BE Q28481005-91A58F80-88E9-45FD-818A-C1ACCD097058 Q28657369-773251B0-0671-4029-B774-E067DC86BE34 Q29960431-F1D81240-C3B1-499A-A467-C8FB4915C5E7 Q30275238-69372C64-CBD4-4750-8E3E-D7BC45ED38F0 Q30276073-A9BF6103-1166-4253-9616-B959AF81C78C Q30276625-B88DD55F-2D94-471E-99CA-2EC7F82E7D06 Q30279308-972ECFE3-6464-46CF-A0BE-2A1844CACA4A Q30303041-7553BBE9-6FD9-4B8B-87C7-43A306429B28 Q30383746-D47A2140-E519-4E2D-B1CE-CF0F4682546D Q30407742-091B4B41-A533-49DF-9012-2F2EA00889AA Q30409292-5232D768-4D73-4BEC-B045-E613BD10DBFC Q30417360-0E164F3F-FB5F-48EA-8114-DC1710DD8410 Q30417426-3FC5233F-1367-49A0-88D8-373C6447043F Q30417919-2AC36BE4-1C20-439E-91F7-84B52A3C8697 Q30422401-0BC9CD6E-691F-496B-9C22-192A06414F8A Q30423072-0F1B46D4-29F3-44B8-BDCA-E1861DE3F4FC Q30423167-301DB02E-5485-4D87-B054-715F1A55A03E Q30424114-16BEBDC2-D0BE-491C-B491-F21947CC0BAD Q30426663-ABAC2B8F-4F9B-4ECB-A17A-AFF820B676EF

P2860

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

http://www.wikidata.org/entity/Q33725032

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Characterization of the severe ...... evere Asthma Research Program.

@ast

Characterization of the severe ...... evere Asthma Research Program.

@en

type

label

Characterization of the severe ...... evere Asthma Research Program.

@ast

Characterization of the severe ...... evere Asthma Research Program.

@en

prefLabel

Characterization of the severe ...... evere Asthma Research Program.

@ast

Characterization of the severe ...... evere Asthma Research Program.

@en

P1433

Q33725032-905A5EC8-9C9B-4AE7-9814-272A888B92AF

P1476

Q33725032-D13E0727-03A7-4FC5-B54C-2B38B34E5617

P2093

Q33725032-0A25D7E8-0787-4C8A-B44A-FD9E44C84F75

Q33725032-0C9B99BA-CBD4-443B-BB8C-06435EACF7D5

Q33725032-1C67AC35-A115-445E-9A92-F65B03C50521

Q33725032-1F8F3394-0B61-428D-8184-B03846404683

Q33725032-218CFA17-E452-47EA-9883-03B38BD37090

Q33725032-249F06C4-71ED-40C8-8B84-FCC8E481948A

Q33725032-2E5EEDAC-7B71-4396-A808-5A76F9CFB078

Q33725032-3680FF72-6175-4BB3-88D6-51F31FEB70D7

Q33725032-36D01C71-A0F8-43FE-A3DE-5228CCD67024

Q33725032-415116F3-AB8D-4CBE-8C22-4BBF76A30E4A

P2860

Q33725032-0294572A-0B75-4A6F-B44B-8A248472B98D

Q33725032-0F392E76-87CD-47D5-9248-AAD7DE424097

Q33725032-1004C2A2-04CB-42D7-9F68-C31142D4E355

Q33725032-2A37E904-2EEF-4BFC-A184-0234C1630A57

Q33725032-2C58FFEC-11F2-44F6-9B52-151D6EA59190

Q33725032-3317B638-A48E-49D9-AB33-E36CBB37CBBD

Q33725032-3D98133B-DBD9-4A72-AC19-0B1FBA16DE54

Q33725032-4357D595-6CE8-428C-BAED-F08B12C97FBC

Q33725032-4F125383-15DF-4CB8-8AD0-FD8369681802

Q33725032-52C3F67C-3535-4AAF-A5E2-961CF21C005F

P304

Q33725032-0B517EA6-34E6-47F9-91CF-BE1810CF86D4

P31

Q33725032-0C59D423-E066-4007-A36C-4F55864579BC

P356

Q33725032-29F2201C-30C8-4CB6-A26B-0ED5B67BD40F

P407

Q33725032-5DCB1498-FB86-400C-9FF6-47C3DC91B66D

P433

Q33725032-408C3DB5-A158-43D7-A317-38F91BA9E577

P478

Q33725032-3F6323AA-9AAA-4C15-8EF7-C09609D2E1FC

P50

Q33725032-523815EF-CC0F-475A-B746-2691D1D9BC11

Q33725032-B3238D59-C7CF-477A-B1D7-4EAB568C7427

Q33725032-C292B88C-8C4F-4922-A797-ADB66E25868D

Q33725032-E0CDE7C7-F5A4-4924-A023-1B18C6F4800A

P577

Q33725032-768F60AA-85D2-4CA6-B8BD-E9D8D0F53F4D

P5875

Q33725032-F5A2C357-AA9B-4083-B507-D99E75C371D0

P698

Q33725032-816E47F7-A992-4997-8BD6-5824C54438DF

P921

Q33725032-1A18F5AA-CEE4-45A8-9ADC-53C3A2B815E8

P932

Q33725032-8BF8D8C1-29BE-46C4-A1A1-420B54E26F05

P356

J.JACI.2006.11.639

P1433

The Journal of Allergy and Clinical Immunology

P1476

Characterization of the severe ...... evere Asthma Research Program.

@en

P2093

Anne M Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Benjamin Gaston

http://www.w3.org/2001/XMLSchema#string

Bill T Ameredes

http://www.w3.org/2001/XMLSchema#string

Bruce D Levy

http://www.w3.org/2001/XMLSchema#string

Deborah A Meyers

http://www.w3.org/2001/XMLSchema#string

Douglas Curran-Everett

http://www.w3.org/2001/XMLSchema#string

Elliot Israel

http://www.w3.org/2001/XMLSchema#string

Iftikhar Hussain

http://www.w3.org/2001/XMLSchema#string

James R Murphy

http://www.w3.org/2001/XMLSchema#string

Mario Castro

http://www.w3.org/2001/XMLSchema#string

P2860

Characterisation of patients with frequent exacerbation of asthma

Standardisation of spirometry

NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response

Categorizing asthma severity: an overview of national guidelines.

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique.

Multiple comparisons: philosophies and illustrations.

Pathophysiology of severe asthma.

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

Exhaled nitric oxide in asthma: from bench to bedside.

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group.

P304

405-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2006.11.639

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

William W Busse

Eugene R Bleecker

Leonard B Bacharier

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6513057

http://www.w3.org/2001/XMLSchema#string

P698

17291857

http://www.w3.org/2001/XMLSchema#string

P921

P932

2837934

http://www.w3.org/2001/XMLSchema#string